Overview
Axon Q2 2025 revenue rises 33% yr/yr, beating analyst expectations
Software & Services revenue grows 39%, driven by premium solutions adoption
Co raises full-year revenue outlook, reflecting confidence in continued growth
Outlook
Axon raises full-year revenue outlook to $2.65 bln-$2.73 bln
Company expects full-year adjusted EBITDA of $665 mln-$685 mln
Axon anticipates 29% annual revenue growth at midpoint
Result Drivers
SOFTWARE & SERVICES - Revenue up 39% due to premium digital evidence management and real-time operations tools
CONNECTED DEVICES - Revenue up 29%, driven by strong demand for TASER 10 and Axon Body 4
PLATFORM SOLUTIONS - Revenue increased 86% reflecting strong market demand for counter-drone and VR training products
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $669 mln | $631.60 mln (14 Analysts) |
Q2 Net Income |
| $36 mln |
|
Q2 Adjusted EBITDA |
| $172 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the aerospace & defense peer group is "buy"
Wall Street's median 12-month price target for Axon Enterprise Inc is $820.00, about 9.5% above its August 1 closing price of $742.47
The stock recently traded at 105 times the next 12-month earnings vs. a P/E of 94 three months ago
Press Release: ID:nPn7TrdPKa